We are live on
!
Find out more
1IA
1620 Investment Advisors Portfolio holdings
AUM
$161M
1-Year Est. Return
30.15%
This Fund
S&P 500
This Quarter
Est. Return
-4.68%
1 Year Est. Return
+30.15%
3 Year Est. Return
+68.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$67.8M
AUM Growth
-$4.74M
(-6.5%)
Cap. Flow
+$3.74M
Cap. Flow
% of AUM
5.52%
Top 10 Holdings %
Top 10 Hldgs %
28.58%
Holding
135
New
9
Increased
73
Reduced
25
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TRI-Continental Corp
TY
|
+$2.25M |
| 2 |
State Street SPDR MSCI EAFE StrategicFactors ETF
QEFA
|
+$1.82M |
| 3 |
Best Buy
BBY
|
+$666K |
| 4 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$361K |
| 5 |
Northrop Grumman
NOC
|
+$318K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RenaissanceRe Holdings 5.75% Series F Preference Share
RNR.PRF
|
+$749K |
| 2 |
AT&T
T
|
+$528K |
| 3 |
FRC.PRK
First Republic Bank Depositary Shares, Each Representing a 1/40th Interest in a Share of 4.125% Noncumulative Perpetual Series K Preferred Stock
FRC.PRK
|
+$494K |
| 4 |
Enbridge
ENB
|
+$348K |
| 5 |
Broadcom
AVGO
|
+$316K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 10.64% |
| 2 | Technology | 10.15% |
| 3 | Energy | 8.78% |
| 4 | Healthcare | 8.69% |
| 5 | Industrials | 7.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Lumen
LUMN
$6.44B
| – | – |
-20,830
| Closed | -$227K |
|
127
Ralph Lauren
RL
$23.6B
| – | – |
-2,269
| Closed | -$203K |
|
|
128
RenaissanceRe Holdings 5.75% Series F Preference Share
RNR.PRF
$207M
| – | – |
-32,395
| Closed | -$749K |
|
129
ProShares Short S&P500
SH
$843M
| – | – |
-102
| Closed | -$221K |
|
|
130
AT&T
T
$163B
| – | – |
-25,168
| Closed | -$528K |
|
131
Theriva Biologics
TOVX
$10.1M
| – | – |
-60
| Closed | -$3K |
|
132
State Street Health Care Select Sector SPDR ETF
XLV
$43.3B
| – | – |
-29,411
| Closed | -$13K |
|
|
FRC.PRK
133
DELISTED
First Republic Bank Depositary Shares, Each Representing a 1/40th Interest in a Share of 4.125% Noncumulative Perpetual Series K Preferred Stock
FRC.PRK
| – | – |
-28,217
| Closed | -$494K |
|
|
ALNA
134
DELISTED
Allena Pharmaceuticals
ALNA
| $0 | ﹤0.01% |
15,000
| – | – |
|
Similar funds
CCW
FC
GPA
SWMG
FPWM
LIM
RCWM
AXA
1620 Investment Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, 1620 Investment Advisors held 135 positions worth $67.8M, down 6.5% from $72.5M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
1620 Investment Advisors deployed $3.74M of net new capital in Q3 2022, opening 9 new positions and adding to 73 existing holdings. Its largest new stake was Best Buy: 8,998 shares worth $570K.
By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Technology and Energy.
On the sell side, the largest reduction was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $243K trimmed.
- 1620 Investment Advisors's largest Q3 2022 buy was Best Buy: 8,998 shares worth $570K.
- 1620 Investment Advisors added most to TRI-Continental Corp in Q3 2022, an estimated $2.25M increase.
- 1620 Investment Advisors's biggest Q3 2022 reduction was iShares JPMorgan USD Emerging Markets Bond ETF, cutting an estimated $243K.
- 1620 Investment Advisors fully exited RenaissanceRe Holdings 5.75% Series F Preference Share in Q3 2022, selling an estimated $749K.
- 1620 Investment Advisors's ten largest holdings make up 29% of its $67.8M portfolio in Q3 2022.
- 1620 Investment Advisors opened 9 new positions and closed 16 in Q3 2022.
- 1620 Investment Advisors's portfolio value fell 6.5% quarter-over-quarter to $67.8M.
Based on 1620 Investment Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.